- Home
- DCGO vs INMB Comparison
DCGO vs INMB Comparison
Compare DCGO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCGO | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 64.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DCGO | INMB |
|---|---|---|
| Price | $0.36 | $2.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $2.38 | ★ $5.40 |
| AVG Volume (30 Days) | ★ 707.5K | 321.5K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $322,196,000.00 | $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.35 | $1.09 |
| 52 Week High | $1.65 | $2.60 |
Technical Indicators
Market Signals| Indicator | DCGO | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 52.36 |
| Support Level | $0.35 | $2.21 |
| Resistance Level | $0.69 | $2.55 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 19.58 | 51.18 |
Price Performance
Historical ComparisonAbout DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.